T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients
Authors:
- 8 March 2023
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 184 (6) , 557-566
Abstract
Introduction: The prevalence of coronavirus disease 2019 (COVID-19) has rapidly increased worldwide. More investigation is needed to progress toward understanding the exact role of immune responses in the pathology of the disease, leading to improved anticipation and treatment options. Methods: In the present study, we examined the relative expression of T-bet, GATA3, RORγt, and FoxP3 transcription factors as well as laboratory indicators in 79 hospitalized patients along with 20 healthy subjects as a control group. In order to make an exact comparison between various degrees of severity of disease, patients were divided into critical (n = 12) and severe (n = 67) groups. To evaluate the expression of genes of interest by performing real-time PCR, blood samples were obtained from each participant. Results: We found a significant increase in the expression of T-bet, GATA3, and RORγt and a reduction in the expression of FoxP3 in the critically ill patients compared to the severe and control groups. Also, we noticed that the GATA3 and RORγt expressions were elevated in the severe group in comparison with healthy subjects. Additionally, the GATA3 and RORγt expressions showed a positive correlation with elevation in CRP and hepatic enzyme concentration. Moreover, we observed that the GATA3 and RORγt expressions were the independent risk factors for the severity and outcome of COVID-19. Discussion: The present study showed that the overexpression of T-bet, GATA3, and RORγt, as well as a decrease in the FoxP3 expression was associated with the severity and fatal outcome of COVID-19.Keywords
This publication has 29 references indexed in Scilit:
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 InfectionCell, 2020
- Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID‐19 in ChongqingJournal of Medical Virology, 2020
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19Allergy, 2020
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Animal Communication: When I’m Calling You, Will You Answer Too?Current Biology, 2017
- Recombinant Canine Coronaviruses in Dogs, EuropeEmerging Infectious Diseases, 2010
- Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenzaCritical Care, 2009
- A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c miceLife Sciences, 2007
- Recent advances in the relationship between obesity, inflammation, and insulin resistance.2006